Digital Health Technology Philips Launches RADIQAL Study to Generate Real-World Evidence for New Ultra-Low X-Ray Dose Technology in Coronary ProceduresMay 21, 2025 Royal Philips announces the launch of the RADIQAL trial to evaluate its new ultra-low X-ray dose technology for coronary procedures, aiming to reduce radiation exposure without compromising image quality.
